About Mackenzie Pharmaceuticals Private Limited
Data last updated:
Mackenzie Pharmaceuticals Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 July 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24240WB2012PTC183671. Its GSTIN is 19AAICM4698M1ZI (West Bengal).
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1 Cr. It is led by directors including Vijay Agarwal and Asha Singh.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 33A J. L. Nehru Road 15th Floor Suit No – A – 11, Kolkata, West Bengal, India – 700071.
As per the financials filed for FY 2025, the company reported a revenue of ₹14.66 Cr, a growth of 31% compared to the previous year. For the same year it recorded a net profit of ₹54.34 Lakh (net margin 3.7%) and EBITDA of ₹87.81 Lakh (EBITDA margin 6%). Revenue has grown at a compounded annual rate (CAGR) of 31% over three years and 23% over five years.
The company has about 79 employees on its provident fund (EPFO) records.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mackenziepharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address33A J. L. Nehru Road 15th Floor Suit No – A – 11, Kolkata, West Bengal, India – 700071
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Mackenzie Pharmaceuticals Private Limited
The main business activity of Mackenzie Pharmaceuticals is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Mackenzie Pharmaceuticals Private Limited FY 2025 filings available
Mackenzie Pharmaceuticals Private Limited reported revenue of ₹14.66 Cr (up 31% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Mackenzie Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 23% over five years, including 31% growth in the latest year. EBITDA rose 489% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Mackenzie Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹87.81 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹54.34 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Mackenzie Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Mackenzie Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Mackenzie Pharmaceuticals Private Limited
Mackenzie Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Neoastra Drugs Private Limited | ₹14.71 Cr (FY 2025) | •••• | •••• | 39.0% | •••• | Sarai Rohilla, Delhi, India |
| Merix Laboratories Private Limited | ₹14.68 Cr (FY 2024) | •••• | •••• | -31.0% | •••• | Hyderabad, Telangana, India |
| Aariva Pharma Private Limited | ₹14.68 Cr (FY 2024) | •••• | •••• | 48.0% | •••• | Savli, Gujarat, India |
| Resonant Pharmaceuticals Private Limited | ₹14.67 Cr (FY 2025) | •••• | •••• | 81.0% | •••• | Navagam, Gujarat, India |
| Ankay Drugs Private Limited | ₹14.66 Cr (FY 2024) | •••• | •••• | -1.0% | •••• | Delhi, India |
| Mackenzie Pharmaceuticals Private Limited this company | ₹14.66 Cr (FY 2025) | •••• | •••• | 31.0% | •••• | Kolkata, West Bengal, India |
| Le Jolly Healthcare Private Limited | ₹14.64 Cr (FY 2024) | •••• | •••• | 119.0% | •••• | Jaipur, Rajasthan, India |
| Emma Trading House India Private Limited | ₹14.63 Cr (FY 2025) | •••• | •••• | •••• | Thrissur, Kerala, India | |
| Katni Hospital Private Limited | ₹14.63 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Katni, Madhya Pradesh, India |
| Adhya Pharmaceuticals Private Limited | ₹14.61 Cr (FY 2024) | •••• | •••• | -32.0% | •••• | Roorkee, Uttarakhand, India |
| Pinima Lifescience Private Limited | ₹14.6 Cr (FY 2024) | •••• | •••• | -18.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Mackenzie Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Mackenzie Pharmaceuticals Private Limited
Mackenzie Pharmaceuticals Private Limited is audited by B.SINGHAL & CO for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| B.SINGHAL & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Mackenzie Pharmaceuticals Private Limited
Mackenzie Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vijay Agarwal | Director | 01 Aug 2018 | 8 Years 2 Months | Current |
| Asha Singh | Director | 12 Jul 2012 | 14 Years 2 Months | Current |
| Ajay Kumar Singh | Director | 12 Jul 2012 | 14 Years 2 Months | Current |
Ownership and Shareholding of Mackenzie Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Mackenzie Pharmaceuticals Private Limited
Mackenzie Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Mackenzie Pharmaceuticals Private Limited
Mackenzie Pharmaceuticals Private Limited has a workforce of 79 employees as of Apr 07, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Mackenzie Pharmaceuticals Private Limited
Mackenzie Pharmaceuticals Private Limited has 4 board changes on record since 2012: 3 appointments and 1 cessation. The latest: Vijay Agarwal ceased to be Additional Director on 29 Sep 2018.
Credit Ratings, Litigation & Regulatory Alerts for Mackenzie Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Mackenzie Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Mackenzie Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Mackenzie Pharmaceuticals Private Limited
Mackenzie Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAICM4698M1ZI | West Bengal | Active | 22 Feb 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Mackenzie Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mackenzie Pharmaceuticals Private Limited
Mackenzie Pharmaceuticals is an active private limited company based in Kolkata, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 July 2012 (14+ years old) and is registered under CIN U24240WB2012PTC183671.
Mackenzie Pharmaceuticals reported revenue of ₹14.66 Cr for FY 2025 (up 31% YoY).
Mackenzie Pharmaceuticals has 3 current directors:
- Vijay Agarwal - Director
- Asha Singh - Director
- Ajay Kumar Singh - Director
Mackenzie Pharmaceuticals reported a net profit of ₹54.34 Lakh (net margin 3.7%) and EBITDA of ₹87.81 Lakh (EBITDA margin 6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Mackenzie Pharmaceuticals is 31% over three years and 23% over five years. In the latest year (FY 2025) revenue rose 31%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Mackenzie Pharmaceuticals is 19AAICM4698M1ZI, registered in West Bengal.
The CIN (Corporate Identification Number) of Mackenzie Pharmaceuticals is U24240WB2012PTC183671. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mackenzie Pharmaceuticals was incorporated on 12 July 2012, making it 14+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Mackenzie Pharmaceuticals by revenue are Neoastra Drugs Private Limited, Merix Laboratories Private Limited, Aariva Pharma Private Limited, Resonant Pharmaceuticals Private Limited, Ankay Drugs Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Vijay Agarwal ceased to be Additional Director on 29 Sep 2018. Vijay Agarwal was appointed as Director on 01 Aug 2018. Ajay Kumar Singh was appointed as Director on 12 Jul 2012. Mackenzie Pharmaceuticals has 4 board changes on record in total.
Mackenzie Pharmaceuticals can be reached through the website mackenziepharma.com. Its registered office is in Kolkata, West Bengal, India.